Chromium |
Lipid-lowering effects, insulin-sensitizing effect by decreasing tyrosine phosphatase activity or direct effect on insulin receptor by increasing tyrosine kinase activity at the insulin receptor may promote glucose transport |
Renal toxicity and dermatological reactions, potential hypoglycemia with secretagogs, steroids may decrease chromium levels, vitamin C may increase chromium absorption |
[27, 52, 117] |
Omega-3 fatty acid/fish oil |
Lowers triglycerides, antiinflammatory, antiplatelet, hypotensive, slight increase in blood glucose |
High intake might cause bleeding, fish meat to be eaten with caution because of contamination with high levels of methyl mercury; may increase LDL, drug interactions with anticoagulant and antihypertension drugs |
[27, 28] |
Alpha-lipoic acid |
Improves insulin resistance and increase glucose effectiveness |
Can affect thyroid function in patients with thyroid disease, might produce allergic skin reactions, abdominal pain, nausea, vomiting, diarrhea, and vertigo |
[28, 52, 122] |
Coenzyme Q10 |
Improvement in pain and paraesthesia in diabetic neuropathy |
No effect on blood glucose, additive effects with antihypertensive drugs |
[21, 28, 52] |
Magnesium |
Insulin secretagog, essential in glucose metabolism, prevent diabetic complications, increased insulin sensitivity |
Diarrhea, abdominal cramping, magnesium toxicity in individuals with renal failure, antibiotics, drug interactions with drugs to prevent osteoporosis, calcium channel blockers, muscle relaxants, diuretics |
[27, 28] |
Zinc |
Improves insulin levels, lipid-lowering effects, improves weight loss, metalloenzyme activitor |
Nausea, vomiting, reduce absorption of folic acid, tetracyclines and copper, reduce the effect of therapies that rely on dopamine receptor antagonists |
[27, 120] |
Vanadium |
Insulin mimetic, increase insulin sensitivity |
Prolonged high doses may cause renal toxicity, gastrointestinal upset |
[28, 52] |